For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...

Evinature, a pioneer in evidence-based nutraceutical formulations designed to support digestive health and help individuals manage chronic bowel challenges, today announced that its proprietary CurQD ...

A global meta-analysis finds that anemia affects 37% of patients with inflammatory bowel disease, highlighting gaps in ...

News and commentary from the world of gastroenterology and hepatology ...

The Crown Heights Crohns and Colitis Support will feature a leading physician, Dr. Michael Dolinger, who has revolutionized IBD care.

Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics ...

A new ulcerative colitis diagnosis can feel overwhelming—but with thoughtful food choices, lifestyle strategies and expert-backed guidance, you can manage flares and feel more like yourself again.

The AMG TimesSquare Small Cap Growth Fund outperformed its benchmark in Q4 2025 behind strong tech and industrial gains. Read ...

Evommune’s role within the NYSE Composite highlights biotechnology research, clinical stage development, financial ...

Capital strengthens the advancement of EQ504 through key clinical milestonesAnticipated net proceeds, along with existing cash and cash ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) that causes inflammation and ulcers in the lining of the colon. This can lead to symptoms such as diarrhea, abdominal pain, ...

March 9, Everest Medicines (1952.HK) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by the issuance of the first prescription at The First ...